Purchase Order 75N91021P00606
Award Date 8/1/21
Potential Completion Date 7/31/24
Potential Value $74K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance services on two BD LSR Fortessa SORP flow cytometers. The contract has a base period of performance from April 17, 2021 through April 16, 2022, with four 12-month option periods, for a total potential value of $80,838. The contract does not have a set-aside designation. BD is a large, for-profit...
- This is a $1,994,840.77 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The contract is for maintenance services on various government-owned BD flow cytometry equipment over the base period ending on July 1, 2026. BD is a global medical technology company that specializes in flow cytometry, cell imaging, and...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the pre-contract inspection of a BD LSRFortessa 4B/2R/2UV 3 laser flow cytometry instrument. The $15,000.00 contract does not have a set-aside designation, reflecting BD's competitive position as a large, established manufacturer of medical technologies and laboratory equipment. The LSRFortessa instrument is...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD). The contract is for preventive maintenance services on a BD LSRFortessa 3 laser flow cytometry system with a high-throughput sampler and an additional laser. The contract has a base period of performance from July 1, 2023, through June 30, 2025, with a ceiling value of $132,357.60. This...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) for a flow cytometry maintenance agreement. The contract has a ceiling value of $353,344.70 and a period of performance through November 29, 2024. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications, including...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the maintenance and support of two BD-manufactured flow cytometry instruments. The contract has a ceiling value of $79,704.00 and a period of performance ending on April 15, 2025. The instruments being maintained are a BD FACSLyric Clinical System and a BD FACS Universal Loader, which are used to support the...
- This is a $750,000.00 firm fixed price purchase order contract awarded by the National Cancer Institute to Becton, Dickinson & Co (BD) for a special order BD Biosciences LSRFortessa X-30 flow cytometer. The contract has no set-aside designation. BD is a manufacturer and supplier of medical devices, instruments, reagents, and related products to healthcare institutions, clinical laboratories, pharmaceutical companies, and the general public. BD has received numerous federal contract awards as...
- This federal contract award is for an annual service agreement with Becton, Dickinson and Company (BD) to provide three LSRFortessa flow cytometers, associated lasers, and one FACS flow supply system to the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH). The $93,612.48 firm fixed-price purchase order does not utilize a small business set-aside. BD, a large medical technology manufacturer, has a long-standing...
- This is a $17,118.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) to provide a service contract to maintain a flow cytometer. The contract period of performance is June 2, 2025 through June 1, 2026. No set-aside designation was used for this award. BD is a global medical technology company that develops, manufactures, and sells medical devices,...
- This is a $126,090.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Becton, Dickinson and Company (BD) for a service contract to provide an LSRFortessa flow cytometer with lasers. The contract does not have a set-aside designation. BD, a large medical technology and manufacturing company, will deliver the flow cytometry instrument to support research activities at the NIH...